Clinical Challenge: An Underdiagnosed Cause of Resistant Hypertension
Once thought to be rare, the prevalence of primary aldosteronism is estimated to be 5% to 17%, although the condition remains underdiagnosed.
Cardiology
Acute Pericarditis, Myopericarditis, and Perimyocarditis in Patients With COVID-19
A patient develops pericarditis 19 days after testing positive test for COVID-19. The authors describe how to recognize, diagnose, and treat this condition.
Gene Therapy Gets Orphan Drug Status for Genetic Hypertrophic Cardiomyopathy
TN-201 is a potentially curative, one-time, AAV-based gene therapy to address genetic hypertrophic cardiomyopathy caused by MYBPC3 gene mutations.
FDA: Consumer Electronics May Impact Implanted Medical Devices
The FDA is advising patients with implanted medical devices to consider keeping consumer electronics at least 6 inches away from the implanted medical device.
Venous Thromboembolism Management in Patients With COVID-19
A 61-year-old woman presents to a rural emergency department with complaints of progressively worsening dyspnea for 24 hours and pleuritic chest pain.
Intravenous IV Vasodilators Remain the First-Line Therapy of Choice for Severe H-AHF
Researchers review the primary clinical and research questions regarding blood pressure (BP) reduction with vasodilators in the early management of hypertensive acute heart failure (H-AHF).
Medical and Surgical Management of Aldosteronism
The authors explore the etiology and clinical presentation of primary and secondary aldosteronism as well as medical and surgical treatment options.
Inflammatory Heart Disease Prevalence in Professional Athletes With Prior COVID-19 Infection
The purpose of this study was to evaluate the prevalence of detectable inflammatory heart disease in professional athletes with prior COVID-19 infection using current RTP screening recommendations.
Medicare Claims Database Useful for Detecting Arrhythmogenic Risk of QT-Prolonging Drugs
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
Racial Disparities Found in Heart Care in the UK During Pandemic
Racial disparities in care for heart patients were seen during the first wave of the COVID-19 pandemic in the United Kingdom.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...